Literature DB >> 29361142

Multiple target autoantigens on endothelial cells identified in juvenile dermatomyositis using proteomics.

Rie Karasawa1, Mayumi Tamaki1, Toshiko Sato1, Megumi Tanaka1, Makiko Nawa2, Kazuo Yudoh1, James N Jarvis3,4.   

Abstract

Objective: Although generally classified within the group of inflammatory myopathies, JDM displays many pathological features of vasculitis. Previous work has shown that AECA are abundant in other forms of vasculitis. We therefore investigated whether such antibodies might also be detected in JDM.
Methods: We screened plasma from children with JDM for the presence of AECA by western blotting and 2D gel electrophoresis (2DE) using proteins extracted from human aortic endothelial cells as the substrate. We performed mass spectrometry to identify candidate antigens from 2DE gels and used ELISA to confirm the presence of specific antibodies.
Results: We identified 22 candidate target autoantigens for AECA probed with JDM plasma. Interestingly, 17 of these 22 target antigens were proteins associated with antigen processing and protein trafficking. ELISA confirmed the presence of antibodies to heat shock cognate 71 kDa protein in JDM plasma, particularly in children with active, untreated disease.
Conclusion: Children with JDM express antibodies to autoantigens in endothelial cells. The clinical and pathological significance of such autoantibodies require further investigation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29361142      PMCID: PMC5888918          DOI: 10.1093/rheumatology/kex468

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  17 in total

1.  Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis.

Authors:  R Karasawa; M S Kurokawa; K Yudoh; K Masuko; S Ozaki; T Kato
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

2.  Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy.

Authors:  J N Whitaker; W K Engel
Journal:  N Engl J Med       Date:  1972-02-17       Impact factor: 91.245

3.  Dermatomyositis (systemic angiopathy) of childhood.

Authors:  B Q Banker; M Victor
Journal:  Medicine (Baltimore)       Date:  1966-07       Impact factor: 1.889

4.  Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction.

Authors:  Boel De Paepe; Kim K Creus; Joachim Weis; Jan L De Bleecker
Journal:  Neuromuscul Disord       Date:  2011-08-19       Impact factor: 4.296

5.  Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development.

Authors:  Martina Mišunová; Tana Svitálková; Lenka Pleštilová; Olga Kryštufková; Dana Tegzová; Radka Svobodová; Marketa Hušáková; Michal Tomčík; Radim Bečvář; Jakub Závada; Herman Mann; Libor Kolesár; Antonij Slavčev; Jiri Vencovský; Peter Novota
Journal:  Clin Exp Rheumatol       Date:  2016-12-28       Impact factor: 4.473

6.  Microvascular alterations and the role of complement in dermatomyositis.

Authors:  Rajat Lahoria; Duygu Selcen; Andrew G Engel
Journal:  Brain       Date:  2016-05-16       Impact factor: 13.501

7.  Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis.

Authors:  W E Crowe; K E Bove; J E Levinson; P K Hilton
Journal:  Arthritis Rheum       Date:  1982-02

8.  Detection of autoantibodies to the 90 kDa heat shock protein in systemic lupus erythematosus and other autoimmune diseases.

Authors:  S E Conroy; G B Faulds; W Williams; D S Latchman; D A Isenberg
Journal:  Br J Rheumatol       Date:  1994-10

Review 9.  Type I interferon pathway in adult and juvenile dermatomyositis.

Authors:  Emily C Baechler; Hatice Bilgic; Ann M Reed
Journal:  Arthritis Res Ther       Date:  2011-12-22       Impact factor: 5.156

Review 10.  Clinical utility of antinuclear antibody tests in children.

Authors:  Julie L McGhee; Lauren M Kickingbird; James N Jarvis
Journal:  BMC Pediatr       Date:  2004-07-09       Impact factor: 2.125

View more
  4 in total

1.  Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis.

Authors:  Rie Karasawa; Kazuo Yudoh; Toshiko Sato; Megumi Tanaka; Mayumi Tamaki; Sara E Sabbagh; Terrance P O'Hanlon; Payam Noroozi-Farhadi; Ira N Targoff; Willy A Flegel; Andrew L Mammen; Frederick W Miller; Mark D Hicar; Lisa G Rider; James N Jarvis
Journal:  Rheumatology (Oxford)       Date:  2022-07-06       Impact factor: 7.046

Review 2.  Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.

Authors:  Judith Wienke; Claire T Deakin; Lucy R Wedderburn; Femke van Wijk; Annet van Royen-Kerkhof
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

Review 3.  Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis.

Authors:  Rochelle L Castillo; Alisa N Femia
Journal:  Ann Transl Med       Date:  2021-03

Review 4.  The Vasculopathy of Juvenile Dermatomyositis.

Authors:  Charalampia Papadopoulou; Liza J McCann
Journal:  Front Pediatr       Date:  2018-10-09       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.